A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies
Clinical trial NCT03370302 · TERMINATED
Trial details
- NCT number
- NCT03370302
- Sponsor
- Calithera Biosciences, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-17
- Primary completion
- 2019-08-28
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.